Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives $22.00 Consensus PT from Brokerages

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has been assigned a consensus rating of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $22.00.

Several analysts have recently commented on the company. Wells Fargo & Company increased their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an “overweight” rating in a report on Thursday, March 26th. Jefferies Financial Group restated a “buy” rating and set a $22.00 target price on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Weiss Ratings raised Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Wednesday, March 18th. Cantor Fitzgerald increased their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Tuesday, February 17th. Finally, Scotiabank boosted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Monday, March 2nd.

Sabra Healthcare REIT Price Performance

SBRA opened at $19.86 on Friday. The firm has a market capitalization of $5.01 billion, a PE ratio of 31.03, a price-to-earnings-growth ratio of 1.58 and a beta of 0.67. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. The business’s 50-day moving average is $19.84 and its two-hundred day moving average is $19.10. Sabra Healthcare REIT has a 1 year low of $15.75 and a 1 year high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm had revenue of $201.35 million for the quarter, compared to analysts’ expectations of $201.97 million. During the same period in the previous year, the company posted $0.36 earnings per share. The business’s quarterly revenue was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts anticipate that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 187.50%.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of large investors have recently made changes to their positions in SBRA. Focus Partners Wealth raised its stake in Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after acquiring an additional 2,375 shares during the last quarter. Creative Planning raised its position in Sabra Healthcare REIT by 17.2% during the 2nd quarter. Creative Planning now owns 35,175 shares of the real estate investment trust’s stock worth $649,000 after buying an additional 5,168 shares during the last quarter. Prudential Financial Inc. raised its position in Sabra Healthcare REIT by 13.9% during the 2nd quarter. Prudential Financial Inc. now owns 37,877 shares of the real estate investment trust’s stock worth $698,000 after buying an additional 4,625 shares during the last quarter. Norges Bank acquired a new stake in Sabra Healthcare REIT during the 2nd quarter valued at approximately $54,385,000. Finally, New York State Common Retirement Fund lifted its stake in Sabra Healthcare REIT by 7.9% during the 2nd quarter. New York State Common Retirement Fund now owns 77,847 shares of the real estate investment trust’s stock valued at $1,435,000 after acquiring an additional 5,700 shares during the period. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.